Kerr and Pezzella Group: Colorectal Clinical and Pathology Group
We lead colorectal cancer clinical trials, and study the basic biology of non-angiogenic and angiogenic tumours and mechanisms of vascular co-option.
Our group is interested in basic and translational aspects of cancer research, with a particular focus on colorectal cancer. Our group discovered the non-angiogenic pathway of cancer growth, which has led to a change in the hallmarks of cancer. We are therefore investigating the biological basis of these tumours and how the use of anti-angiogenic drugs has changed. For this we are running international trials in colorectal cancer, looking at the interaction between anti-angiogenic drugs and chemotherapy.